Your browser doesn't support javascript.
loading
The effect of prednisolone on symptom severity in schizophrenia: A placebo-controlled, randomized controlled trial.
Nasib, Lyliana G; Gangadin, Shiral S; Rossum, Inge Winter-van; Boudewijns, Zimbo S R M; de Witte, Lot D; Wilting, Ingeborg; Luykx, Jurjen; Somers, Metten; Veen, Natalie; van Baal, Caroline; Kahn, René S; Sommer, Iris E.
Affiliation
  • Nasib LG; Department of Psychiatry, University Medical Center Utrecht, Utrecht University, UMC Brain Center, Utrecht, the Netherlands. Electronic address: Lnasib@umcutrecht.nl.
  • Gangadin SS; Department of Psychiatry, University Medical Center Utrecht, Utrecht University, UMC Brain Center, Utrecht, the Netherlands; University of Groningen, University Medical Center Groningen, Department of Biomedical Sciences of Cells & Systems, Cognitive Neurosciences, Groningen, the Netherlands.
  • Rossum IW; Department of Psychiatry, University Medical Center Utrecht, Utrecht University, UMC Brain Center, Utrecht, the Netherlands.
  • Boudewijns ZSRM; Department of Psychiatry, University Medical Center Utrecht, Utrecht University, UMC Brain Center, Utrecht, the Netherlands.
  • de Witte LD; Department of Psychiatry, Icahn School of Medicine, Mount Sinai, NY, the United States of America.
  • Wilting I; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Luykx J; Department of Psychiatry, University Medical Center Utrecht, Utrecht University, UMC Brain Center, Utrecht, the Netherlands; Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Outpatient Second Opinion
  • Somers M; Department of Psychiatry, University Medical Center Utrecht, Utrecht University, UMC Brain Center, Utrecht, the Netherlands.
  • Veen N; GGZ Delfland, Delft, the Netherlands.
  • van Baal C; Department of Biostatistics and Research Support, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Kahn RS; Department of Psychiatry, University Medical Center Utrecht, Utrecht University, UMC Brain Center, Utrecht, the Netherlands; Department of Psychiatry, Icahn School of Medicine, Mount Sinai, NY, the United States of America.
  • Sommer IE; University of Groningen, University Medical Center Groningen, Department of Biomedical Sciences of Cells & Systems, Cognitive Neurosciences, Groningen, the Netherlands.
Schizophr Res ; 230: 79-86, 2021 04.
Article in En | MEDLINE | ID: mdl-33711681
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Schizophrenia / Antipsychotic Agents Type of study: Clinical_trials / Diagnostic_studies Limits: Humans Language: En Journal: Schizophr Res Journal subject: PSIQUIATRIA Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Schizophrenia / Antipsychotic Agents Type of study: Clinical_trials / Diagnostic_studies Limits: Humans Language: En Journal: Schizophr Res Journal subject: PSIQUIATRIA Year: 2021 Type: Article